{
 "name": "醣基",
 "slug": "tw-6586",
 "aliases": [
  "醣基生醫股份有限公司",
  "CHO",
  "6586"
 ],
 "ticker": "6586",
 "industry": "生技醫療業",
 "website": "www.chopharma.com",
 "summary": "醣基（6586）是興櫃的生技醫療類股公司，2013 年成立，2017 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "醣基生醫股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "CHO",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2017-09-27",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2013-03-08",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "陳肇隆",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "吳宗益",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 2140105000,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "勤業眾信聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "www.chopharma.com",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "管線：CHO-H01",
   "value": "復發或難治性非何杰金氏淋巴瘤、單藥或合併lenalidomide｜第I/II期、活躍但不再招募｜台灣",
   "unit": "",
   "as_of": "2026-08-17",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT05950165",
   "note": "NCT05950165；ClinicalTrials.gov最後公開更新 2026-08-17；登錄狀態 ACTIVE_NOT_RECRUITING。"
  },
  {
   "claim": "催化劑：CHO-H01",
   "value": "NCT05950165主要完成日（登錄估計）｜2026-12-23（公司登錄預估）｜已公告",
   "unit": "",
   "as_of": "2026-08-17",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT05950165",
   "note": "NCT05950165；由試驗主辦方登錄的Estimated Primary Completion Date，並非解盲、核准或已完成。"
  },
  {
   "claim": "管線：CHO-A04",
   "value": "晚期惡性實體腫瘤｜TFDA核准啟動第I期臨床試驗｜台灣",
   "unit": "",
   "as_of": "2026-02-26",
   "source": "https://www.chopharma.com/news.html?news_no=95",
   "note": "NCT07049458；核准臨床試驗不是藥品上市核准。"
  },
  {
   "claim": "管線：CHO-A04",
   "value": "晚期實體腫瘤｜FDA核准啟動第I期臨床試驗｜美國",
   "unit": "",
   "as_of": "2025-08-09",
   "source": "https://www.chopharma.com/news.html?news_no=90",
   "note": "NCT07049458；登錄的實際試驗中心在台灣；此筆僅記美國IND核准。"
  },
  {
   "claim": "管線：CHO-V08（K1/K2克雷伯氏肺炎桿菌二價醣蛋白疫苗）",
   "value": "預防高致病性克雷伯氏肺炎桿菌K1/K2感染｜第I期已公告期中分析、持續一年追蹤｜台灣",
   "unit": "",
   "as_of": "2026-09-24",
   "source": "https://www.chopharma.com/news.html?news_no=102",
   "note": "NCT07016152（KLEBBI-001）；初期安全性及免疫生成性不等同保護效力或藥證。"
  },
  {
   "claim": "催化劑：CHO-V08",
   "value": "第I期臨床試驗總結報告完成｜2027Q2（公司預估）｜已公告",
   "unit": "",
   "as_of": "2026-09-24",
   "source": "https://www.chopharma.com/news.html?news_no=102",
   "note": "公司註明取決於最後一位受試者最後訪視及整體數據分析進度。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-6586.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}